179 related articles for article (PubMed ID: 27521607)
1. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
[TBL] [Abstract][Full Text] [Related]
2. Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2020 May; 213():195-202. PubMed ID: 31926883
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.
Felix JP; Lira RP; Zacchia RS; Toribio JM; Nascimento MA; Arieta CE
Am J Ophthalmol; 2014 Apr; 157(4):762-766.e1. PubMed ID: 24388839
[TBL] [Abstract][Full Text] [Related]
4. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.
Silveira C; Belfort R; Muccioli C; Holland GN; Victora CG; Horta BL; Yu F; Nussenblatt RB
Am J Ophthalmol; 2002 Jul; 134(1):41-6. PubMed ID: 12095806
[TBL] [Abstract][Full Text] [Related]
5. OUTCOMES AFTER PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANES ASSOCIATED WITH TOXOPLASMOSIS.
Miranda AF; Costa de Andrade G; Novais EA; Maia A; Nascimento H; Muccioli C; Belfort R
Retina; 2016 Sep; 36(9):1713-7. PubMed ID: 26982340
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
Fox BC; Sollinger HW; Belzer FO; Maki DG
Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.
Stanford MR; See SE; Jones LV; Gilbert RE
Ophthalmology; 2003 May; 110(5):926-31; quiz 931-2. PubMed ID: 12750091
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trials of prophylaxis of toxoplasmic retinochoroiditis recurrences by immunotherapy using B.C.G. (author's transl)].
Bonnet M; Garin JP; La Falce E
J Fr Ophtalmol; 1980; 3(11):653-5. PubMed ID: 7204877
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis.
Matet A; Paris L; Fardeau C; Terrada C; Champion E; Fekkar A; Cassoux N; Touitou V; LeHoang P; Bodaghi B
Am J Ophthalmol; 2019 Mar; 199():82-93. PubMed ID: 30502335
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine.
Maki DG; Fox BC; Kuntz J; Sollinger HW; Belzer FO
J Lab Clin Med; 1992 Jan; 119(1):11-24. PubMed ID: 1727903
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.
Baharivand N; Mahdavifard A; Fouladi RF
Int Ophthalmol; 2013 Feb; 33(1):39-46. PubMed ID: 23053769
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Long-term Intermittent Trimethoprim/Sulfamethoxazole Treatment on Recurrences of Toxoplasmic Retinochoroiditis: 10 Years of Follow-up.
Silveira C; Muccioli C; Nussenblatt R; Belfort R
Ocul Immunol Inflamm; 2015 Jun; 23(3):246-7. PubMed ID: 25325434
[No Abstract] [Full Text] [Related]
17. Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy.
Bu LN; Chen HL; Chang CJ; Ni YH; Hsu HY; Lai HS; Hsu WM; Chang MH
J Pediatr Surg; 2003 Apr; 38(4):590-3. PubMed ID: 12677572
[TBL] [Abstract][Full Text] [Related]
18. Posterior segment findings by spectral-domain optical coherence tomography and clinical associations in active toxoplasmic retinochoroiditis.
Oliver GF; Ferreira LB; Vieira BR; Arruda S; Araújo M; Carr JM; Smith JR; Furtado JM
Sci Rep; 2022 Jan; 12(1):1156. PubMed ID: 35064148
[TBL] [Abstract][Full Text] [Related]
19. Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
Winterhalter S; Severing K; Stammen J; Maier AK; Godehardt E; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1187-92. PubMed ID: 20437247
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-γ +874 T/A as risk factors for recurrence in a survival analysis.
Aleixo ALQDC; Vasconcelos C de Oliveira R; Cavalcanti Albuquerque M; Biancardi AL; Land Curi AL; Israel Benchimol E; Reis Amendoeira MR
PLoS One; 2019; 14(2):e0211627. PubMed ID: 30753197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
